AXQ Capital’s Bristol-Myers Squibb BMY Stock Holding History

AXQ Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,117	Closed	-$1.83M	–	1021
2026 Q1	$1.83M	Buy	+30,117	New	+$1.76M	0.24%	124
2025 Q4	–	Sell	-38,456	Closed	-$1.73M	–	741
2025 Q3	$1.73M	Buy	38,456 +949	+3%	+$44.3K	0.66%	7
2025 Q2	$1.74M	Buy	37,507 +28,051	+297%	+$1.38M	0.56%	23
2025 Q1	$577K	Buy	+9,456	New	+$551K	0.23%	153
2024 Q3	–	Sell	-51,983	Closed	-$2.16M	–	441
2024 Q2	$2.16M	Buy	+51,983	New	+$2.33M	0.5%	39
2024 Q1	–	Sell	-5,700	Closed	-$292K	–	637
2023 Q4	$292K	Buy	+5,700	New	+$299K	0.08%	388
2023 Q3	–	Sell	-4,100	Closed	-$262K	–	473
2023 Q2	$262K	Sell	4,100 -25,190	-86%	-$1.69M	0.32%	141
2023 Q1	$2.03M	Buy	29,290 +11,098	+61%	+$783K	0.81%	3
2022 Q4	$1.31M	Buy	+18,192	New	+$1.37M	0.91%	10

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AXQ Capital's BMY Position: Q2 2026 in Review

AXQ Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 30,117 shares — an estimated $1.83M sold.

AXQ Capital first reported a position in BMY in Q4 2022 and held it in 9 quarters. The position peaked at $2.16M in Q2 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

AXQ Capital reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 30,117 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.83M.
AXQ Capital first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 9 quarters.
AXQ Capital's Bristol-Myers Squibb position peaked at $2.16M in Q2 2024.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.